OM	oral mucositis
RCT	randomized controlled trial
HSCT	hematopoietic stem cell transplant
WHO	World Health Organization
GVHD	graft-versus-host disease
HL	Hodgkin lymphoma
NHL	non-Hodgkin’s lymphoma
MAC	myeloablative conditioning
BEAM	BCNU, etoposide (VP-16), and cytarabine
BUCY(2)	busulfan and cyclophosphamide
CYTBI	cyclophosphamide and total body irradiation
FLUBU	fludarabine and busulfan
THIOFLUBU	thiotepa, fludarabine, and busulfan
RIC	reduced intensity conditioning
FLAMZA	fludarabine, cytarabine, and idarubicin
FLUCYTBI	fludarabine, cyclophosphamide, and total body irradiation
FLUCY	fludarabine and cyclophosphamide
FLUTBI	fludarabine and total body irradiation
CTC (AE)	Common Terminology Criteria (for adverse events)
NCI	National Cancer Institute
MM	multiple myeloma
HSV	herpes simplex virus
HDM	high dose melphalan
RSV	respiratory syncytial virus
FLUMEL	fludarabine and melphalan
GLIM	Global Leadership Initiative on Malnutrition
TNF-α	Tumor Necrosis Factor-α
IL-6	Interleukin 6
IL-1β	Interleukin 1β